Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia · Delayed Price · Currency is SAR 122.40
+1.00 (0.82%)
Nov 19, 2025, 10:05 AM AST
TADAWUL:4016 Revenue
Middle East Pharmaceutical Industries Company had revenue of 107.95M SAR in the quarter ending September 30, 2025, with 33.17% growth. This brings the company's revenue in the last twelve months to 458.96M, up 18.54% year-over-year. In the year 2024, Middle East Pharmaceutical Industries Company had annual revenue of 394.00M with 16.42% growth.
Revenue (ttm)
458.96M
Revenue Growth
+18.54%
P/S Ratio
5.29
Revenue / Employee
726.19K
Employees
632
Market Cap
2.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 394.00M | 55.56M | 16.42% |
| Dec 31, 2023 | 338.44M | 35.78M | 11.82% |
| Dec 31, 2022 | 302.66M | 15.44M | 5.38% |
| Dec 31, 2021 | 287.22M | -14.44M | -4.79% |
| Dec 31, 2020 | 301.66M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition